BETA(2)-ADRENOCEPTORS BUT NOT BETA(3)-ADRENOCEPTORS MEDIATE PREJUNCTIONAL INHIBITION OF NONADRENERGIC NONCHOLINERGIC CONTRACTION OF GUINEA-PIG MAIN BRONCHI
Rej. Tenberge et al., BETA(2)-ADRENOCEPTORS BUT NOT BETA(3)-ADRENOCEPTORS MEDIATE PREJUNCTIONAL INHIBITION OF NONADRENERGIC NONCHOLINERGIC CONTRACTION OF GUINEA-PIG MAIN BRONCHI, European journal of pharmacology, 275(2), 1995, pp. 199-206
We studied the effects of selective beta-adrenoceptor agonists on the
cholinergic and non-adrenergic non-cholinergic (excitatory NANC) contr
actions elicited by electrical field stimulation of guinea pig main br
onchi in vitro. Addition of the selective beta(2)-adrenoceptor agonist
s, fenoterol and salbutamol, and the selective beta(3)-adrenoceptor ag
onist, BRL 37344 (3-chlor-phenyl)ethyl)amino]-propyl]-phenoxyacetic ac
id), induced a dose-dependent inhibition of the cholinergic contractio
n (pD(2) 7.89, 6.71 and 4.56, respectively) and the excitatory NANC re
sponse (pD(2) 9.11, 8.16 and 7.42, respectively). Fenoterol- and BRL 3
7344-induced inhibition of the excitatory NANC response was blocked wi
th high potency (pK(B) 8.77 and 9.07, respectively) by the selective b
eta(2)-adrenoceptor antagonist, ICI 118,511 thylindan-4-yloxy)-3-(isop
ropylamino)-butan-2-ol). A comparable contraction induced by neurokini
n A (2 or 5 nM) was also inhibited by fenoterol, salbutamol and BRL 37
344, but at significantly higher concentrations than for the inhibitio
n of the excitatory NANC response (pD(2) 8.72, 7.56 and 6.66, respecti
vely). Such a preferential inhibition of electrical field stimulation-
versus agonist-induced effects was not observed for cholinergic contr
actions (pD(2) versus methacholine-induced tone 7.86, 6.93 and 5.10, r
espectively). The results clearly exclude the involvement of beta(3)-a
drenoceptors in these responses. Furthermore they show that beta(2)-ad
renoceptors are involved in the prejunctional inhibition of excitatory
NANC contractions, presumably via modulation of tachykinin release fr
om sensory nerves, and solely in the postjunctional inhibition of chol
inergic contractions.